SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma board to consider Un-Audited Financial Results

29 Jul 2013 Evaluate

Aurobindo Pharma has informed that a Meeting of the Board of Directors of the Company will be held on August 09, 2013, to consider the Un-Audited Financial Results of the Company for the quarter ended June 30, 2013 (Q1).

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1575.85 27.00 (1.74%)
30-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.70
Dr. Reddys Labs. 1356.85
Cipla 1465.15
Zydus Lifesciences 1112.20
Lupin 2420.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: